HALISTER: 3M Co FY EPS Forecast Midpoint Trails Est.

3M Co FY EPS Forecast Midpoint Trails Est.

(Bloomberg) -- 3M Co sees FY EPS $8.45 to $8.80, est. $8.64
  • 4Q EPS $1.88, est. $1.87 (range $1.86-$1.88)
  • 4Q net sales $7.33b, est. $7.35b (range $7.26b-$7.47b)
  • 4Q operating margin 22.7%
NOTE:
  • 8 buys, 10 holds, 2 sells before today
  • Call 9am (NY time), (800)-762-2596
Statement
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
MMM US (3M Co)

To de-activate this alert, click here

UUID: 7947283

HALISTER: Travelers 4Q Operating EPS Beats Highest Est.

Travelers 4Q Operating EPS Beats Highest Est.

(Bloomberg) -- Travelers 4Q operating EPS $3.20, est. $2.81 (range $2.57-$3.10)
  • 4Q rev. $7.19b, est. $6.99b (range $6.81b-$7.12b)
  • 4Q net premiums written $6.06b
NOTE:
  • 7 buys, 14 holds, 4 sells before today
  • Call 9am (NY time), 800-732-5617 pw 14788
Statement
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
TRV US (Travelers Cos Inc/The)

To de-activate this alert, click here

UUID: 7947283

HALISTER: J&J 4Q Adj. EPS Beats Est.

J&J 4Q Adj. EPS Beats Est.

(Bloomberg) -- J&J 4Q adj. EPS $1.58, est. $1.56 (range $1.54-$1.62)
  • 4Q sales $18.1b, est. $18.3b (range $17.7b-$18.6b)
  • 4Q Remicade rev. $1.62b, est. $1.64b (Bloomberg data, average of 3)
    • 4Q Stelara rev. $879m, est. $881.7m
    • 4Q Xarelto rev. $598m, est. $559.7m
    • 4Q Imbruvica rev. $346m, est. $377m (average of 2)
    • 4Q Invokana rev. $371m, est. $387.7m
    • 4Q Olysio rev. $10m, est. $33m (1 est.)
  • 4Q worldwide medical devices sales $6.44b
  • Sees FY adj. EPS $6.93 to $7.08
NOTE:
  • 10 buys, 15 holds, 0 sells before today
  • Call 8:30am (NY time), 877-869-3847
Statement
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
JNJ US (Johnson & Johnson)
MRK US (Merck & Co Inc)
4508 JP (Mitsubishi Tanabe Pharma Corp)

To de-activate this alert, click here

UUID: 7947283